ClinicalWaikato

Regional Diabetes Service: Diabetes and Chronic Kidney Disease program

Published: 2 July 2025

The Diabetes and Chronic Kidney Disease program aims to slow progression of CKD leading to end-stage renal disease and other diabetes related complications. The aims (below) are achieved by partnering with the patient/whanau, sharing matauranga/knowledge, improving self-management skills and strategies, and enabling appropriate treatment intensification. For people living with suboptimal diabetes (Hbalc greater than 53 mmol/mol) and CKD 3B or earlier (eGFR 30 ml/min and above), please see the referral criteria and pathway in Appendix 1, for guidance . Aims of intensive management Optimise treatment by progressing therapy as appropriate and by improving patient expertise on self-management on the following parameters. Blood glucose levels. Blood pressure. Lipid profile. Other CVD risk factor reduction (i.e. advise on smoking cessation, weight management, ideal exercise according to current best practise guidelines). Risk reduction of other diabetes-related complications that contribute to reduced quality of life (i.e. retinopathy, neuropathy, loss of limb). Provide knowledge and skills training that promote medication adherence and healthy lifestyle habits.